Literature DB >> 25766697

Nocturnal Hypoxemia and Severe Obstructive Sleep Apnea are Associated with Incident Type 2 Diabetes in a Population Cohort of Men.

Sarah L Appleton1, Andrew Vakulin2,3, R Doug McEvoy2,4, Gary A Wittert1,5, Sean A Martin5, Janet F Grant6, Anne W Taylor6, Nick A Antic2,4, Peter G Catcheside2,4, Robert J Adams1.   

Abstract

STUDY
OBJECTIVES: Studies examining the longitudinal association of untreated obstructive sleep apnea (OSA) with diabetes in population samples are limited. This study therefore examined the relationship between previously undiagnosed OSA with incident type 2 diabetes in community-dwelling men aged ≥ 40 y.
METHODS: The Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) Study is a longitudinal population-based cohort in Adelaide, South Australia. Clinic assessments at baseline and follow-up identified diabetes (self-reported doctor diagnosed, fasting plasma glucose ≥ 7.0 mmol/L, glycated hemoglobin ≥ 6.5% or diabetes medication use) and included anthropometry. At cohort follow-up (2010-2012), n = 837 underwent full in-home unattended polysomnography (PSG, Embletta X100, Broomfield, CO).
RESULTS: Of 736 men free of diabetes at baseline, incident diabetes occurred in 66 (9.0%) over a mean follow-up time of 56 mo (standard deviation = 5, range: 48-74 mo). Incident diabetes was associated with current oxygen desaturation index (3%) ≥ 16 events/h (odds ratio [OR]: 1.85 [1.06-3.21]), and severe OSA [OR: 2.6 (1.1-6.1)], in adjusted models including age, percentage total body fat, and weight gain (> 5 cm waist circumference). An age-adjusted association of incident diabetes with percentage of total sleep time with oxygen saturation < 90% did not persist after adjustment for percentage of body fat. No modification of these relationships by excessive daytime sleepiness was observed.
CONCLUSIONS: Severe undiagnosed OSA and nocturnal hypoxemia were independently associated with the development of diabetes. A reduction in the burden of undiagnosed OSA and undiagnosed diabetes is likely to occur if patients presenting with one disorder are assessed for the other.
© 2015 American Academy of Sleep Medicine.

Entities:  

Keywords:  cohort study; epidemiology; men; nocturnal hypoxemia; obstructive sleep apnea; polysomnography; type 2 diabetes

Mesh:

Year:  2015        PMID: 25766697      PMCID: PMC4442221          DOI: 10.5664/jcsm.4768

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  25 in total

Review 1.  Sleep, sleep-disordered breathing and metabolic consequences.

Authors:  P Lévy; M R Bonsignore; J Eckel
Journal:  Eur Respir J       Date:  2009-07       Impact factor: 16.671

2.  Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up.

Authors:  Yelda Turgut Celen; Jan Hedner; Jan Carlson; Yüksel Peker
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

3.  Association of sleep apnea and type II diabetes: a population-based study.

Authors:  Kevin J Reichmuth; Diane Austin; James B Skatrud; Terry Young
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

4.  Obstructive sleep apnea is independently associated with insulin resistance.

Authors:  Mary S M Ip; Bing Lam; Matthew M T Ng; Wah Kit Lam; Kenneth W T Tsang; Karen S L Lam
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

5.  Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?

Authors:  Nathaniel S Marshall; Keith K H Wong; Craig L Phillips; Peter Y Liu; Matthew W Knuiman; Ronald R Grunstein
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

6.  Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes.

Authors:  Samuel T Kuna; David M Reboussin; Kelley E Borradaile; Mark H Sanders; Richard P Millman; Gary Zammit; Anne B Newman; Thomas A Wadden; John M Jakicic; Rena R Wing; F Xavier Pi-Sunyer; Gary D Foster
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

Review 7.  Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review.

Authors:  Tetyana Kendzerska; Tatyana Mollayeva; Andrea S Gershon; Richard S Leung; Gillian Hawker; George Tomlinson
Journal:  Sleep Med Rev       Date:  2013-05-01       Impact factor: 11.609

8.  Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study.

Authors:  Brian D Kent; Ludger Grote; Maria R Bonsignore; Tarja Saaresranta; Johan Verbraecken; Patrick Lévy; Pawel Sliwinski; Ruzena Tkacova; John-Arthur Kvamme; Ingo Fietze; Jan Hedner; Walter T McNicholas
Journal:  Eur Respir J       Date:  2014-04-02       Impact factor: 16.671

9.  Obstructive sleep apnea and type 2 diabetes: is there a link?

Authors:  Sushmita Pamidi; Esra Tasali
Journal:  Front Neurol       Date:  2012-08-13       Impact factor: 4.003

10.  Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study.

Authors:  Sinziana Seicean; H Lester Kirchner; Daniel J Gottlieb; Naresh M Punjabi; Helaine Resnick; Mark Sanders; Rohit Budhiraja; Mendel Singer; Susan Redline
Journal:  Diabetes Care       Date:  2008-02-11       Impact factor: 19.112

View more
  23 in total

1.  Effect of high-intensity aerobic exercise on aerobic fitness and HbA1c in patients with type 2 diabetes.

Authors:  Tomoyuki Kawada
Journal:  Eur J Appl Physiol       Date:  2017-05-15       Impact factor: 3.078

2.  Effect of Three Hypopnea Scoring Criteria on OSA Prevalence and Associated Comorbidities in the General Population.

Authors:  Camila Hirotsu; Jose Haba-Rubio; Daniela Andries; Nadia Tobback; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber; Raphael Heinzer
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

3.  CrossTalk opposing view: Sleep apnoea causes metabolic syndrome.

Authors:  Craig L Phillips; Camilla M Hoyos; Brendon J Yee; Ronald R Grunstein
Journal:  J Physiol       Date:  2016-06-30       Impact factor: 5.182

4.  Associations of Undiagnosed Obstructive Sleep Apnea and Excessive Daytime Sleepiness With Depression: An Australian Population Study.

Authors:  Carol J Lang; Sarah L Appleton; Andrew Vakulin; R Doug McEvoy; Andrew D Vincent; Gary A Wittert; Sean A Martin; Janet F Grant; Anne W Taylor; Nicholas Antic; Peter G Catcheside; Robert J Adams
Journal:  J Clin Sleep Med       Date:  2017-04-15       Impact factor: 4.062

Review 5.  Obstructive Sleep Apnea and Diabetes: A State of the Art Review.

Authors:  Sirimon Reutrakul; Babak Mokhlesi
Journal:  Chest       Date:  2017-05-17       Impact factor: 9.410

Review 6.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

7.  Circulating C3 and glucose metabolism abnormalities in patients with OSAHS.

Authors:  Xiaoxia Lu; Xiao Wang; Ting Xu; Yuan Feng; Yufeng Wang; Zechuan Cai; Bing Cao; Taoping Li
Journal:  Sleep Breath       Date:  2017-09-07       Impact factor: 2.816

8.  Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients.

Authors:  Josko Bozic; Tea Galic; Daniela Supe-Domic; Natalija Ivkovic; Tina Ticinovic Kurir; Zoran Valic; Josip Lesko; Zoran Dogas
Journal:  Endocrine       Date:  2016-03-21       Impact factor: 3.633

Review 9.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

10.  Body mass index and neuropsychological and emotional variables: joint contribution for the screening of sleep apnoea syndrome in obese.

Authors:  Olga Rodrigues Ribeiro; Isabel do Carmo; Teresa Paiva; Maria Luísa Figueira
Journal:  Sleep Sci       Date:  2021 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.